Oncology Expert and Early-Phase Drug Development Chief
us
Vivek Subbiah is an Oncology Expert and Early-Phase Drug Development Chief with 40.5K followers across 1 platform, ranked #3 in Health & Medicine (Oncology & Cancer) (Top 7%).
Last updated
Vivek Subbiah, MD, is a Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, specializing in oncology, phase 1 clinical trials, and precision medicine. He actively shares insights on cancer research, drug development, and professional networking through Twitter. His posts frequently highlight his participation in medical conferences, presentations of groundbreaking research, and collaborations with leading oncologists and institutions. Subbiah’s content is deeply rooted in advancing cancer treatment and fostering a global oncology community.
The future of oncology is bright.
Search interest grew +3.6% over last 9 months (slow).
| Social Media | Score | Followers | Eng. rate | Growth | Last Activity |
|---|---|---|---|---|---|
| Vivek Subbiah@viveksubbiah | 81/100 | 40.5K | 0.08% | 0.5%+210 | Last month |
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
